This page is part of the FHIR Specification (v4.5.0: R5 Preview #3). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3
Pharmacy Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Encounter, Patient, Practitioner |
Raw JSON (canonical form + also see JSON Format Specification)
Dispense for Nystatin Topical Ointment (RxNorm code) - completed
{ "resourceType": "MedicationDispense", "id": "meddisp0324", "text": { "status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><p><b>id</b>: meddisp0324</p><p><b>status</b>: completed</p><p><b>medication</b>: </p><p><b>subject</b>: <a>Donald Duck. Generated Summary: id: pat1; Medical record number: 654321 (USUAL); active; Duck Donald (OFFICIAL); gender: male; </a></p><h3>Performers</h3><table><tr><td>-</td><td><b>Actor</b></td></tr><tr><td>*</td><td><a>Generated Summary: id: f006; id: 937223645 (OFFICIAL), id: 134IDY41W988 (USUAL); Rob van den Berk (OFFICIAL); ph: 0205569288(WORK), R.A.vandenberk@bmc.nl(WORK), fax: 0205664987(WORK); gender: male; birthDate: 1975-12-07</a></td></tr></table><p><b>authorizingPrescription</b>: <a>Generated Summary: id: medrx0321; id: 12345689 (OFFICIAL); status: active; intent: order; <span>Novolog 100u/ml</span>; authoredOn: 2015-01-15; <span>Diabetes mellitus type 2 (disorder)</span>; Check blood sugar levels before taking insulin; </a></p><p><b>type</b>: <span>Refill - Part Fill</span></p><p><b>quantity</b>: 30 g</p><p><b>daysSupply</b>: 10 Day</p><p><b>whenPrepared</b>: 15/01/2015 9:20:00 PM</p><p><b>whenHandedOver</b>: 16/01/2015 3:20:00 AM</p><p><b>dosageInstruction</b>: </p></div>" }, "status": "completed", "medication": { "concept": { "coding": [ { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "code": "884375", "display": "Nystex 100,000 UNT/GM Topical Ointment" } ] } }, "subject": { "reference": "Patient/pat1", "display": "Donald Duck" }, "performer": [ { "actor": { "reference": "Practitioner/f006" } } ], "authorizingPrescription": [ { "reference": "MedicationRequest/medrx0321" } ], "type": { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/v3-ActCode", "code": "RFP", "display": "Refill - Part Fill" } ] }, "quantity": { "value": 30, "system": "http://unitsofmeasure.org", "code": "g" }, "daysSupply": { "value": 10, "unit": "Day", "system": "http://unitsofmeasure.org", "code": "d" }, "whenPrepared": "2015-01-15T10:20:00Z", "whenHandedOver": "2015-01-15T16:20:00Z", "dosageInstruction": [ { "sequence": 1, "text": "Apply to affected areas four times daily", "timing": { "repeat": { "frequency": 4, "period": 1, "periodUnit": "d" } }, "doseAndRate": [ { "type": { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/dose-rate-type", "code": "ordered", "display": "Ordered" } ] }, "doseQuantity": { "value": 1, "unit": "ea", "system": "http://terminology.hl7.org/CodeSystem/v3-orderableDrugForm", "code": "OINT" } } ] } ] }
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.